ArticleProceedings of the National Academy of Sciences of the United States of America2016

Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.

Madelon Q Wentink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.